Yeruusaalem, 8 January, 2026 (TPS-IL) — Shirkadda Israa’iil ee falanqaynta kiimikada kombiyuuterada, Evogene Ltd., ayaa la-hawlgalaysaa Unravel Biosciences oo fadhigeedu yahay Boston si ay u horumariso daawayn nooc cusub ah oo loogu talagalay hagaajinta dhaawaca neerfaha ee cudurrada ay sababto burburka myelin, sida xanuunka ‘multiple sclerosis’.
Iskaashiga wuxuu isku daraa madal Evogene ee ChemPass oo ku shaqaysa AI (sirdoonka macmal) ee naqshadaynta molecules-ka yar yar ee la soo saari karo, iyo nidaamka Unravel ee BioNAV ee laga helo bukaanka iyo ‘Living Molecular Twins’. Si wada jir ah, waxay doonayaan inay aqoonsadaan oo ay hagaajiyaan molecules-ka geli kara maskaxda kuwaas oo awood u leh inay dib u soo celiyaan myelin-ka iyo inay dib u rogaan burburka neerfaha—baahi aan weli la daboolin daawaynta hadda jirta oo diiradda saarta oo kaliya gaabinta horumarka cudurka. Codsiyada caafimaad ee la filayo waxay ku fidi karaan xaalado kale oo adag oo neerfaha ah.